Most patients will not die from follicularlymphoma, and that's very reassuring.
大部分患者将不会死于滤泡性淋巴瘤，这是非常肯定的。
2
Objective To discuss the differential diagnosis between tumor-like follicular hyperplasia and follicularlymphoma.
目的讨论淋巴滤泡瘤样增生与滤泡性淋巴瘤的鉴别诊断。
3
The PI3K deltainhibitor idelalisib (Zydelig) and the BTK inhibitor ibrutinib (Imbruvica) have shown promise for patients with relapsed follicularlymphoma.